EX 3 – role of posttranslationak 2018-09-15T12:35:28+00:00

The role of posttranslational modifications of amyloid peptides in Alzheimer’s Disease and related neurodegenerative disorders

Wednesday, 10.10.2018 | 10:30 am – 12:00 pm

10:30 –
10:50 am
Hans-Ulrich Demuth
(Halle (Saale), Germany)
The Role of Posttranslational Modifications of Amyloid-ß for Neurotoxicity and Resulting Therapeutic Opportunities
10:50 –
11:10 am
Cynthia A. Lemere
(Boston, USA)
Focused ultrasound improves the efficacy of passive immunotherapy targeting pyroglutamate-3 Aβ
11:10 –
11:30 am
Thore Hettmann
(Halle (Saale), Germany)
Characterization of PBD-C06 – an anti-pyroglutamate-3 Aβ antibody for immunotherapy of Alzheimer’s Disease
11:30 –
11:45 am
Jochen Walter
(Bonn, Germany)
Differential aggregation and deposition of post-translationally modified Aβ peptides in Alzheimer”s disease
11:45 –
12:00 pm
Stephan  Schilling
(Halle (Saale), Germany)
Monoclonal antibodies targeting isoaspartate-modified amyloid peptides